We combined our proprietary light and camera technologies to create the modular ArthroFree wireless camera system for minimally invasive surgery.
By eliminating surgical tower components (and the connecting cables), the ArthroFree wireless system has the potential to add substantial value across the healthcare system—reducing costs by improving safety and efficiency in the operating room.
When we interviewed surgeons about the operating room, they focused on workflow inefficiencies, and told us over and over:
Forty years after its invention, the legacy camera still connects to the surgical tower via cables, which are associated with patient burns and healthcare-associated infections (HAIs).
To eliminate the cables, we combined:
The MLE has potential applications as a power-and-light component in multiple industries, including healthcare, aerospace, and manufacturing.2
ArthroFree™ Stakeholder Surgeons.
The US arthroscopic market:
arthroscopic operating rooms
cameras per operating room
camera replacement cycle
new camera purchases per year
In the US, surgeons perform more than 5.4 million arthroscopic surgeries every year. We plan to introduce ArthroFree first to the US market in 2022 ($1.35 billion, 2019; CAGR = 5.4%) and, soon thereafter, the global arthroscopic market (US $4.1 billion, 2019; CAGR = 6.3%). Likewise, our ArthroFree technology platform has potential application in endoscopic surgical specialties.
Minimally invasive surgery continues to be the preferred option for treatments as wide ranging as tumor resection to complex spinal pathology. And that’s especially the case at ambulatory surgery centers (ASCs), which have widespread favor over hospitals due to cost savings. New ASCs mean newly equipped tech suites, for orthopedics and beyond.
Demonstration of the ArthroFree™ System.
US(x2), Australia, and Japan
Registered in Australia, China, Europe, Hong Kong, and UK
US, China, Hong Kong, and Japan
Registered in Australia, Europe, Hong Kong and UK
The ArthroFree wireless surgical camera system is not yet FDA approved. The approval pathway for the ArthroFree system is as a non-de-novo 510(k) under Sec. 888.1100 HRX as a Class II surgical device.